Barclays analyst Andrew Mok CFA maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of $642.00. The ...

The most recent trading session ended with UnitedHealth Group (UNH) standing at $524.70, reflecting a -0.07% shift from the previouse trading day's closing. This change was narrower than the S&P 500's ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price ...

UnitedHealth Group stock has passed through the first phase of becoming a good contrarian idea. Check out my recommendation ...

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to ...

UNH, HUM and CNC are likely to navigate industry ... S&P 500 is down 1.7% over the past six months, UnitedHealth’s stock price has fallen further to $523.02, losing shareholders 10.3% of their ...

UnitedHealth Group named Tim Noel the new CEO of the company's insurance division, UnitedHealthcare, after the targeted killing of former CEO Brian Thompson. UnitedHealth Group CEO Andrew Witty ...

UnitedHealth's 2025 guidance reflects optimism with expected revenue growth of 13% and EPS growth of 7%, aiming for a "normal" year. See more on UNH stock here.

No significant news for UNH in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...